This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hagens Berman Advises NuVasive Investors Of Oct. 28, 2013, Class-action Deadline And Continuing Investigation

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today advised investors of the Oct. 28, 2013, deadline to move to be a lead plaintiff in a securities class-action lawsuit filed against NuVasive, Inc. (NASDAQ:NUVA) (“NuVasive”), following the company’s disclosure of a federal administrative subpoena from the Office of the Inspector General (OIG) of the Department of Health and Human Services (DHHS). Investors are invited to inquire about their options with Hagens Berman attorneys by emailing

If you purchased NuVasive common stock between Oct. 22, 2008, and July 30, 2013 (the “Class Period”) and suffered significant financial losses, you may also contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation, by calling (510) 725-3000. You can submit information online at

On July 30, 2013, NuVasive announced that it had received a subpoena from DHHS’ Office of the Inspector General relating to possible false Medicare and Medicaid claims. Following the announcement, the company’s stock price fell more than 10 percent.

Hagens Berman’s investigation centers on what NuVasive knew regarding improper Medicare and Medicaid claims before the July 30, 2013, announcement. In particular, the firm is investigating whether NuVasive or its officers had reason to believe that potential issues could have a significant material impact on the company’s financial condition.

“DHHS’ investigation includes a request for documents going back to early 2007,” said Mr. Kathrein. “Our concern is that NuVasive may have been aware of issues very early, and only just recently has been caught. If so, we believe the company is responsible for the losses of shareholders following the disclosure of the probe.”

Persons with non-public information may want to consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs